Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi-Year Returns And Recent Share Price Momentum [Yahoo! Finance]
Edgewise Therapeutics, Inc. (EWTX)
Company Research
Source: Yahoo! Finance
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Edgewise Therapeutics overview Edgewise Therapeutics (EWTX) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance alongside meaningful gains over the past 3 months and year to date. See our latest analysis for Edgewise Therapeutics. At a share price of US$30.12, Edgewise Therapeutics has seen a 15.67% 90 day share price return and a very large 221.79% three year total shareholder return, which suggests that recent momentum has built on a much longer rerating as investors reassess its risk and potential. If this type of move has you looking for other high growth stories in the sector, our screener of 30 healthcare AI stocks is a useful place to start spotting the next set of ideas. After a strong three year total return, a recent 90 day gain of 1
Show less
Read more
Impact Snapshot
Event Time:
EWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EWTX alerts
High impacting Edgewise Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
EWTX
News
- Edgewise Therapeutics to Present at the Leerink Global Healthcare Conference on March 11, 2026PR Newswire
- Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific ConferencePR Newswire
- Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesPR Newswire
- Edgewise Therapeutics (EWTX) was upgraded by HC Wainwright to "strong-buy".MarketBeat
EWTX
Earnings
- 2/26/26 - Miss
EWTX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- EWTX's page on the SEC website